Comparison of two strategies of peripheral blood progenitor cells induction with lenalidomide/dexamethasone in newly diagnosed multiple myeloma patients, followed by transplantation and lenalidomide maintenance treatment

Autor:	Eduardo Ríos Herranz, Antonio Alcalá Muñoz, Gemma Ramirez, Antonio Fernández Jurado, José Joaquín Ruíz Arredondo, Francisco Javier Capote Huelva, José Luís Guzmán Zamudio, Miguel Ángel Álvarez Rivas, Alicia Bailén Garcia
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty Mobilization business.industry medicine.disease Peripheral Blood Stem Cells law.invention Transplantation Randomized controlled trial law Internal medicine Medicine Progenitor cell business Multiple myeloma Dexamethasone medicine.drug Lenalidomide
Zdroj:	Hematology and Leukemia. 6:4
ISSN:	2052-434X
DOI:	10.7243/2052-434x-6-4
Popis:	Background: The most common therapy in young multiple myeloma patients include induction, mobilization, collection and graft of peripheral blood stem cells. The present phase 2, multi-center, randomized study
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::58451ce45a4221216ddc8689b023116b https://doi.org/10.7243/2052-434x-6-4 Zobrazit plný text záznamu